KNIGHT PETER S
Insider CIK 1189792 · BIAF Director · MRX Director · PRX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| BIAF bioAffinity Technologies, | A Award | 2024-07-01 | 2024-07-02 | 33,784 | — | $0 | 117,455 | SEC↗ |
| BIAF bioAffinity Technologies, | A Award | 2024-06-12 | 2024-06-14 | 8,296 | — | $0 | 83,671 | SEC↗ |
| BIAF bioAffinity Technologies, | A Award | 2024-01-01 | 2024-01-24 | 12,668 | $1.48 | $18.7K | 75,375 | SEC↗ |
| BIAF bioAffinity Technologies, | A Award | 2023-10-01 | 2024-01-24 | 11,867 | $1.58 | $18.7K | 62,707 | SEC↗ |
| BIAF bioAffinity Technologies, | A Award | 2023-07-01 | 2023-07-06 | 10,245 | $1.83 | $18.7K | 50,840 | SEC↗ |
| BIAF bioAffinity Technologies, | A Award | 2023-04-15 | 2023-07-06 | 9,920 | $1.89 | $18.7K | 40,595 | SEC↗ |
| BIAF bioAffinity Technologies, | A Award | 2023-01-01 | 2023-07-06 | 8,227 | $2.28 | $18.8K | 30,675 | SEC↗ |
| BIAF bioAffinity Technologies, | P Buy deriv | 2022-08-31 | 2022-12-05 | 8,163 | — | $0 | 8,163 | SEC↗ |
| BIAF bioAffinity Technologies, | P Buy deriv | 2022-08-31 | 2022-12-05 | 8,163 | — | $0 | 8,163 | SEC↗ |
| BIAF bioAffinity Technologies, | P Buy | 2022-08-31 | 2022-12-05 | 8,163 | — | $0 | 22,448 | SEC↗ |
| MRX MEDICIS PHARMACEUTICAL COR | D To issuer deriv | 2012-12-11 | 2012-12-13 | 21,000 | $14.70 | $308.7K | 0 | SEC↗ |
| MRX MEDICIS PHARMACEUTICAL COR | D To issuer deriv | 2012-12-11 | 2012-12-13 | 15,000 | $21.21 | $318.1K | 0 | SEC↗ |
| MRX MEDICIS PHARMACEUTICAL COR | D To issuer deriv | 2012-12-11 | 2012-12-13 | 15,000 | $10.19 | $152.8K | 0 | SEC↗ |
| MRX MEDICIS PHARMACEUTICAL COR | D To issuer deriv | 2012-12-11 | 2012-12-13 | 7,500 | $11.65 | $87.4K | 0 | SEC↗ |
| MRX MEDICIS PHARMACEUTICAL COR | D To issuer deriv | 2012-12-11 | 2012-12-13 | 15,000 | $20.38 | $305.7K | 0 | SEC↗ |
| MRX MEDICIS PHARMACEUTICAL COR | D To issuer deriv | 2012-12-11 | 2012-12-13 | 7,743 | $6.15 | $47.6K | 0 | SEC↗ |
| MRX MEDICIS PHARMACEUTICAL COR | D To issuer deriv | 2012-12-11 | 2012-12-13 | 21,000 | $4.96 | $104.2K | 0 | SEC↗ |
| MRX MEDICIS PHARMACEUTICAL COR | D To issuer deriv | 2012-12-11 | 2012-12-13 | 6,842 | $7.71 | $52.8K | 0 | SEC↗ |
| MRX MEDICIS PHARMACEUTICAL COR | D To issuer deriv | 2012-12-11 | 2012-12-13 | 15,000 | $11.44 | $171.6K | 0 | SEC↗ |
| MRX MEDICIS PHARMACEUTICAL COR | D To issuer deriv | 2012-12-11 | 2012-12-13 | 15,000 | $28.11 | $421.6K | 0 | SEC↗ |
| MRX MEDICIS PHARMACEUTICAL COR | D To issuer | 2012-12-11 | 2012-12-13 | 12,532 | $44.00 | $551.4K | 0 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | D To issuer deriv | 2012-09-28 | 2012-10-02 | 10,000 | $1.25 | $12.5K | 0 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | D To issuer deriv | 2012-09-28 | 2012-10-02 | 5,000 | $7.86 | $39.3K | 0 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | D To issuer deriv | 2012-09-28 | 2012-10-02 | 10,000 | $18.30 | $183.0K | 0 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | D To issuer deriv | 2012-09-28 | 2012-10-02 | 30,090 | $50.00 | $1.50M | 0 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | D To issuer deriv | 2012-09-28 | 2012-10-02 | 22,782 | $50.00 | $1.14M | 0 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | D To issuer deriv | 2012-09-28 | 2012-10-02 | 5,000 | $23.62 | $118.1K | 0 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | D To issuer deriv | 2012-09-28 | 2012-10-02 | 5,000 | $16.38 | $81.9K | 0 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | D To issuer | 2012-09-28 | 2012-10-02 | 3,500 | $50.00 | $175.0K | 0 | SEC↗ |
| MRX MEDICIS PHARMACEUTICAL COR | M Exercise deriv | 2012-08-23 | 2012-08-27 | 3,500 | — | $0 | 0 | SEC↗ |
| MRX MEDICIS PHARMACEUTICAL COR | S Sale | 2012-08-23 | 2012-08-27 | 3,500 | $32.16 | $112.6K | 12,532 | SEC↗ |
| MRX MEDICIS PHARMACEUTICAL COR | M Exercise | 2012-08-23 | 2012-08-27 | 3,500 | $20.44 | $71.5K | 16,032 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | A Award deriv | 2012-07-02 | 2012-07-05 | 583 | $36.50 | $21.3K | 22,782 | SEC↗ |
| MRX MEDICIS PHARMACEUTICAL COR | A Award deriv | 2012-05-15 | 2012-05-17 | 7,743 | — | $0 | 7,743 | SEC↗ |
| MRX MEDICIS PHARMACEUTICAL COR | A Award | 2012-05-15 | 2012-05-17 | 2,311 | — | $0 | 12,532 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | A Award deriv | 2012-04-02 | 2012-04-04 | 534 | $39.80 | $21.3K | 22,199 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | M Exercise deriv | 2012-03-19 | 2012-03-21 | 7,500 | — | $0 | 0 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | S Sale | 2012-03-19 | 2012-03-21 | 700 | $37.05 | $25.9K | 4,800 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | S Sale | 2012-03-19 | 2012-03-21 | 1,300 | $37.05 | $48.2K | 3,500 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | S Sale | 2012-03-19 | 2012-03-21 | 100 | $37.03 | $3.7K | 5,500 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | S Sale | 2012-03-19 | 2012-03-21 | 500 | $37.03 | $18.5K | 5,600 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | S Sale | 2012-03-19 | 2012-03-21 | 600 | $37.02 | $22.2K | 6,100 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | S Sale | 2012-03-19 | 2012-03-21 | 800 | $37.01 | $29.6K | 6,700 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | S Sale | 2012-03-19 | 2012-03-21 | 3,500 | $37.01 | $129.5K | 7,500 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | M Exercise | 2012-03-19 | 2012-03-21 | 7,500 | $28.79 | $215.9K | 11,000 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | A Award deriv | 2012-01-05 | 2012-01-09 | 3,816 | — | $0 | 30,090 | SEC↗ |
| PRX PAR PHARMACEUTICAL COMPANI | A Award deriv | 2012-01-03 | 2012-01-04 | 655 | $32.45 | $21.3K | 21,665 | SEC↗ |